Ambulatory Neuroproprioceptive Facilitation and Inhibition Physical Therapy Does Not Modulate Serum Level of Neuroactive Steroids

CompletedNot a drug-phase studyMS (type not specified)NCT04379193

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Neuroproprioceptive facilitation and inhibition physical therapy

What it measured

Main measures

  • serum level of neuroactive steroids

    2 months

Other measures (4)

  • Berg Balance Scale, BBS outcomes

    2 months

    Walking and mobility
  • Paced Auditory Serial Addition Test

    2 months

    Thinking and memory
  • the 29-item Multiple Sclerosis Impact Scale, MSIS -29

    2 months

    Quality of life (reported by participants)
  • Modified Fatigue Impact Scale

    2 months

    Fatigue

Who could take part

MS (type not specified) · 18 to 70

Show the full criteria

Inclusion criteria

* prevailed spastic paraparesis, stable clinical status and treatment in the preceding 3 months determined by neurologist, * Expanded Disability Status Scale score (EDSS) max. 7.5

Exclusion criteria

* other neurological disease or conditions disabling movement

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This study describes modulation of neuroproprioceptive facilitation and inhibition physical therapy on serum level of neuroactive steroids in multiple sclerosis.

Papers

Loading reviews and guidelines…

History

    1. Started

      May 2015

    2. Main results due

      May 2017

    3. Finished

      Sept 2019

    Assembled by software from public sources.